Remove 2023 Remove Coronary Artery Disease Remove Myocardial Infarction
article thumbnail

Safe Deferral of Coronary Computed Tomography Angiography for Patients With a Low Pretest Probability of Coronary Artery Disease in 2019 European Society of Cardiology Guidelines

Journal of the American Heart Association

Journal of the American Heart Association, Volume 12, Issue 23 , December 5, 2023. BackgroundCoronary computed tomography angiography is increasingly used as the firstā€line test for suspected coronary artery disease. PTP was calculated according to the 2013 and 2019 ESC guidelines.

article thumbnail

Abstract 9: Efficacy of Colchicine for Prevention of Stroke and Major Adverse Cardiovascular Events in Patients With Coronary Artery Disease: A Meta-Analysis of 15 Randomized Controlled Trials

Stroke Journal

0.81), P>0.001), myocardial infarction by 40% (OR, 0.60 (95%CI: 0.44-0.84), 0.84), P>0.001), new acute coronary syndrome by 53% (OR, 0.47(95%CI: Odds ratios (OR) were pooled using a random-effect model, and a p-value of <0.05 0.85), P>0.001), and major adverse cardiovascular events 45% (OR, 0.55(95%CI:

article thumbnail

HeartFlow Announces Revolutionary Five-Year Data Demonstrating a 63 Percent Mortality Reduction with FFRCT-Guided Care in PAD Patients

DAIC

1 Atherosclerosis is a systemic disease that affects multiple vascular regions and is particularly severe in PAD patients, where up to 80 percent suffer from concurrent coronary artery disease (CAD), historically linked with a mortality rate exceeding 50 percent within five years. 10390, May 2023, pp.

article thumbnail

7 Things You Can Do To Reduce Your Risk Even If You Already Have Heart Disease.

Dr. Paddy Barrett

A common feedback I get is that people with existing coronary artery disease feel like it doesn’t apply to them. Arguably, applying the principles of prevention offers more bang for buck in the short term for people WITH coronary artery disease than those without coronary artery disease.

article thumbnail

Immediate vs. multistage revascularization of non-infarct coronary artery(-ies) in patients with hemodynamically stable multivessel disease acute myocardial infarction: a systematic review and meta-analysis

Coronary Artery Disease Journal

Background Untreated multivessel disease (MVD) in acute myocardial infarction (AMI) has been linked to a higher risk of recurrent ischemia and death within one year. Databases were searched for relevant articles published before 10 November 2023.

article thumbnail

Treatment of coronary lesions with a novel crystalline sirolimus-coated balloon

Frontiers in Cardiovascular Medicine

Background There is mounting data supporting the use of drug-coated balloons (DCB) not only for treatment of in-stent restenosis (ISR), but also in native coronary artery disease. So far, paclitaxel-coated balloons represented the mainstay DCBs. Angiograms and outcomes were independently adjudicated.

article thumbnail

Role of Left Ventricular Ejection Fraction in Modern High-Risk PCI with pLVAD Support

Cardiology Update

In the early years of percutaneous coronary intervention (PCI), studies indicated a heightened risk of major adverse cardiac events (MACE) in patients with reduced left ventricular ejection fraction (LVEF), involving outcomes such as death, Q-wave myocardial infarction (MI), stent thrombosis, and repeat revascularization.